191 related articles for article (PubMed ID: 30378269)
1. Chemical Control System of Epigenetics.
Vaijayanthi T; Pandian GN; Sugiyama H
Chem Rec; 2018 Dec; 18(12):1833-1853. PubMed ID: 30378269
[TBL] [Abstract][Full Text] [Related]
2. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
4. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
5. Small molecule control of chromatin remodeling.
Finley A; Copeland RA
Chem Biol; 2014 Sep; 21(9):1196-210. PubMed ID: 25237863
[TBL] [Abstract][Full Text] [Related]
6. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
7. Multitarget Drugs: an Epigenetic Epiphany.
Ganesan A
ChemMedChem; 2016 Jun; 11(12):1227-41. PubMed ID: 26891251
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
9. Oncoepigenomics: making histone lysine methylation count.
Decarlo D; Hadden MK
Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
[TBL] [Abstract][Full Text] [Related]
10. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
11. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
Furdas SD; Kannan S; Sippl W; Jung M
Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
14. Chemistry-Driven Epigenetic Investigation of Histone and DNA Modifications.
Sueoka T; Koyama K; Hayashi G; Okamoto A
Chem Rec; 2018 Dec; 18(12):1727-1744. PubMed ID: 30070422
[TBL] [Abstract][Full Text] [Related]
15. Histone methylases as novel drug targets: developing inhibitors of EZH2.
Baugé C; Bazille C; Girard N; Lhuissier E; Boumediene K
Future Med Chem; 2014; 6(17):1943-65. PubMed ID: 25495986
[TBL] [Abstract][Full Text] [Related]
16. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
17. Small-molecular modulators of cancer-associated epigenetic mechanisms.
Itoh Y; Suzuki T; Miyata N
Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
19. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata.
Zhao M; Liang G; Wu X; Wang S; Zhang P; Su Y; Yin H; Tan Y; Zhang J; Lu Q
Br J Dermatol; 2012 Feb; 166(2):226-73. PubMed ID: 21936853
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]